About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 672760, 9 pages
http://dx.doi.org/10.1155/2012/672760
Review Article

Therapeutic Strategies Based on Polymeric Microparticles

1Center for Integrative Medicine and Innovative Science (CIMIS), Facultad de Medicina, Universidad Andrés Bello, Santiago, Echaurren 183, 8370071 Santiago, Chile
2Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Avenida Ecuador 3493, 9170124 Santiago, Chile

Received 14 December 2011; Revised 28 February 2012; Accepted 13 March 2012

Academic Editor: Soldano Ferrone

Copyright © 2012 C. Vilos and L. A. Velasquez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Reichert, “Trends in development and approval times for new therapeutics in the United States,” Nature Reviews Drug Discovery, vol. 2, no. 9, pp. 695–702, 2003. View at Scopus
  2. J. A. DiMasi, R. W. Hansen, and H. G. Grabowski, “The price of innovation: new estimates of drug development costs,” Journal of Health Economics, vol. 22, no. 2, pp. 151–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mullard, “2011 FDA drug approvals,” Nature Reviews Drug Discovery, vol. 11, pp. 91–94, 2012. View at Publisher · View at Google Scholar
  4. R. Ottenbrite, “Controlled release technology,” in Encyclopedia of Polymer Science and Engineering, J. I. Kroschwitz, Ed., Wiley, New York, NY, USA, 1990.
  5. P. A. Sales-Junior, F. Guzman, M. I. Vargas, et al., “Use of biodegradable PLGA microspheres as a slow release delivery system for the Boophilus microplus synthetic vaccine SBm7462,” Veterinary Immunology and Immunopathology, vol. 107, no. 3-4, pp. 281–290, 2005. View at Publisher · View at Google Scholar
  6. J. Urquhart, “Controlled drug delivery: therapeutic and pharmacological aspects,” Journal of Internal Medicine, vol. 248, no. 5, pp. 357–376, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. Verma, S. Arora, and S. Garg, “Osmotic pumps in drug delivery,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 21, no. 6, pp. 477–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. W. T. Al-Jamal and K. Kostarelos, “Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine,” Accounts of Chemical Research, vol. 44, no. 10, pp. 1094–1104, 2011. View at Publisher · View at Google Scholar
  9. A. Jesorka and O. Orwar, “Liposomes: technologies and analytical applications,” Annual Review of Analytical Chemistry, vol. 1, no. 1, pp. 801–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Hoffman, “Hydrogels for biomedical applications,” Advanced Drug Delivery Reviews, vol. 54, no. 1, pp. 3–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Cabral and S. C. Moratti, “Hydrogels for biomedical applications,” Future Medicinal Chemistry, vol. 3, pp. 1877–1888, 2011.
  12. N. A. Peppas, Y. Huang, M. Torres-Lugo, J. H. Ward, and J. Zhang, “Physicochemical foundations and structural design of hydrogels in medicine and biology,” Annual Review of Biomedical Engineering, vol. 2, no. 2000, pp. 9–29, 2000. View at Scopus
  13. W. Jiang, R. K. Gupta, M. C. Deshpande, and S. P. Schwendeman, “Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens,” Advanced Drug Delivery Reviews, vol. 57, no. 3, pp. 391–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Mathiowitz, J. S. Jacob, Y. S. Jong et al., “Biologically erodable microspheres as potential oral drug delivery systems,” Nature, vol. 386, no. 6623, pp. 410–414, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. B. D. Ulery, L. S. Nair, and C. T. Laurencin, “Biomedical applications of biodegradable polymers,” Journal of Polymer Science B, vol. 49, no. 12, pp. 832–864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. D. Bendrea, L. Cianga, and I. Cianga, “Review paper: progress in the field of conducting polymers for tissue engineering applications,” Journal of Biomaterials Applications, vol. 26, no. 1, pp. 3–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Pillai and R. Panchagnula, “Polymers in drug delivery,” Current Opinion in Chemical Biology, vol. 5, no. 4, pp. 447–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. G. M. Keegan, J. D. Smart, M. J. Ingram, L. M. Barnes, G. R. Burnett, and G. D. Rees, “Chitosan microparticles for the controlled delivery of fluoride,” Journal of Dentistry, vol. 40, no. 3, pp. 229–240, 2012.
  19. K. Moebus, J. Siepmann, and R. Bodmeier, “Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces,” European Journal of Pharmaceutical Sciences, vol. 45, no. 3, pp. 358–366, 2012.
  20. S. A. Meenach, Y. J. Kim, K. J. Kauffman, N. Kanthamneni, E. M. Bachelder, and K. M. Ainslie, “Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery,” Molecular Pharmacology, vol. 9, no. 2, pp. 290–298, 2012. View at Publisher · View at Google Scholar
  21. Z. S. Patel, H. Ueda, M. Yamamoto, Y. Tabata, and A. G. Mikos, “In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds,” Pharmaceutical Research, vol. 25, no. 10, pp. 2370–2378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. N. Lee, Y. Ye, J. H. Carr, K. Karem, and M. J. D'Souza, “Formulation, pharmacokinetics and biodistribution of Ofloxacin-loaded albumin microparticles and nanoparticles,” Journal of Microencapsulation, vol. 28, no. 5, pp. 363–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Fernandez, J. Chang, J. Fontaine, et al., “Activation of invariant Natural Killer T lymphocytes in response to the alpha-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles,” International Journal of Pharmaceutics, vol. 423, no. 1, pp. 45–54, 2012.
  24. W. Chen and Y. W. Tong, “PHBV microspheres as neural tissue engineering scaffold support neuronal cell growth and axon-dendrite polarization,” Acta Biomaterialia, vol. 8, no. 2, pp. 540–548, 2012.
  25. N. B. Shelke and T. M. Aminabhavi, “Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine,” International Journal of Pharmaceutics, vol. 345, no. 1-2, pp. 51–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. R. Balmayor, G. A. Feichtinger, H. S. Azevedo, M. Van Griensven, and R. L. Reis, “Starch-poly-ε-caprolactone microparticles reduce the needed amount of BMP-2,” Clinical Orthopaedics and Related Research, vol. 467, no. 12, pp. 3138–3148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. W. B. Liechty, D. R. Kryscio, B. V. Slaughter, and N. A. Peppas, “Polymers for drug delivery systems,” Annual Review of Chemical and Biomolecular Engineering, vol. 1, pp. 149–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Curcio, U. Gianfranco Spizzirri, F. Iemma et al., “Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 1, pp. 48–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Ma, M. Liu, and X. Shi, “pH- and temperature-sensitive self-assembly microcapsules/microparticles: synthesis, characterization, in vitro cytotoxicity, and drug release properties,” Journal of Biomedical Materials Research B, vol. 100, no. 2, pp. 305–313, 2012. View at Publisher · View at Google Scholar
  30. K. Rizi, R. J. Green, O. Khutoryanskaya, M. Donaldson, and A. C. Williams, “Mechanisms of burst release from pH-responsive polymeric microparticles,” Journal of Pharmacy and Pharmacology, vol. 63, no. 9, pp. 1141–1155, 2011. View at Publisher · View at Google Scholar
  31. M. A. Alhnan, E. Kidia, and A. W. Basit, “Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles,” European Journal of Pharmaceutics and Biopharmaceutics, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. N. Aamir and M. Ahmad, “Production and stability evaluation of modified-release microparticles for the delivery of drug combinations,” AAPS PharmSciTech, vol. 11, no. 1, pp. 351–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Wieber, T. Selzer, and J. Kreuter, “Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: a comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes,” International Journal of Pharmaceutics, vol. 421, no. 1, pp. 151–159, 2011.
  34. G. Winzenburg, C. Schmidt, S. Fuchs, and T. Kissel, “Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems,” Advanced Drug Delivery Reviews, vol. 56, no. 10, pp. 1453–1466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Engelberg and J. Kohn, “Physico-mechanical properties of degradable polymers used in medical applications: a comparative study,” Biomaterials, vol. 12, no. 3, pp. 292–304, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Yang, D. Plackett, D. Needham, and H. M. Burt, “PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections,” Pharmaceutical Research, vol. 26, no. 7, pp. 1644–1656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Jia, D. Chen, X. Jiao, and S. Zhai, “Environmentally-friendly preparation of water-dispersible magnetite nanoparticles,” Chemical Communications, no. 8, pp. 968–970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Zhao, J. Gagnon, and U. O. Hafeli, “Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres,” BioMagnetic Research and Technology, vol. 5, p. 2, 2007. View at Publisher · View at Google Scholar
  39. S. Mao, J. Xu, C. Cai, O. Germershaus, A. Schaper, and T. Kissel, “Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres,” International Journal of Pharmaceutics, vol. 334, no. 1-2, pp. 137–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Yegian and V. Budd, “Novobiocin: activity in vitro and in experimental tuberculosis,” American Review of Tuberculosis, vol. 76, no. 2, pp. 272–278, 1957.
  41. Z. T. Cygan, J. T. Cabral, K. L. Beers, and E. J. Amis, “Microfluidic platform for the generation of organic-phase microreactors,” Langmuir, vol. 21, no. 8, pp. 3629–3634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Karnik, F. Gu, P. Basto et al., “Microfluidic platform for controlled synthesis of polymeric nanoparticles,” Nano Letters, vol. 8, no. 9, pp. 2906–2912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. P. M. Valencia, P. A. Basto, L. Zhang et al., “Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing,” ACS Nano, vol. 4, no. 3, pp. 1671–1679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. F. Christopher, N. N. Noharuddin, J. A. Taylor, and S. L. Anna, “Experimental observations of the squeezing-to-dripping transition in T-shaped microfluidic junctions,” Physical Review E, vol. 78, no. 3, Article ID 036317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Xu, M. Hashimoto, T. T. Dang et al., “Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery,” Small, vol. 5, no. 13, pp. 1575–1581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Vehring, “Pharmaceutical particle engineering via spray drying,” Pharmaceutical Research, vol. 25, no. 5, pp. 999–1022, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Niwa, H. Shimabara, M. Kondo, and K. Danjo, “Design of porous microparticles with single-micron size by novel spray freeze-drying technique using four-fluid nozzle,” International Journal of Pharmaceutics, vol. 382, no. 1-2, pp. 88–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. S. M. D'Addio, J. G. Chan, P. C. Kwok, R. K. Prud'homme, and H. K. Chan, “Constant size, variable density aerosol particles by ultrasonic spray freeze drying,” International Journal of Pharmaceutics, vol. 427, no. 2, pp. 185–191, 2012.
  49. A. Göpferich, “Mechanisms of polymer degradation and erosion,” Biomaterials, vol. 17, no. 2, pp. 103–114, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Göpferich and J. Tessmar, “Polyanhydride degradation and erosion,” Advanced Drug Delivery Reviews, vol. 54, no. 7, pp. 911–931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. F. V. Burkersroda, L. Schedl, and A. Göpferich, “Why degradable polymers undergo surface erosion or bulk erosion,” Biomaterials, vol. 23, no. 21, pp. 4221–4231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Xu and P. I. Lee, “Programmable drug delivery from an erodible assocation polymer system,” Pharmaceutical Research, vol. 10, no. 8, pp. 1144–1152, 1993. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Faisant, J. Siepmann, and J. P. Benoit, “PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release,” European Journal of Pharmaceutical Sciences, vol. 15, no. 4, pp. 355–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. B. S. Zolnik and D. J. Burgess, “Effect of acidic pH on PLGA microsphere degradation and release,” Journal of Controlled Release, vol. 122, no. 3, pp. 338–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. H. T. Wang, H. Palmer, R. J. Linhardt, D. R. Flanagan, and E. Schmitt, “Degradation of poly(ester) microspheres,” Biomaterials, vol. 11, no. 9, pp. 679–685, 1990. View at Publisher · View at Google Scholar · View at Scopus
  56. R. van Dijkhuizen-Radersma, S. C. Hesseling, P. E. Kaim, K. De Groot, and J. M. Bezemer, “Biocompatibility and degradation of poly(ether-ester) microspheres: in vitro and in vivo evaluation,” Biomaterials, vol. 23, no. 24, pp. 4719–4729, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Demuth and M. E. Berens, “Molecular mechanisms of glioma cell migration and invasion,” Journal of Neuro-Oncology, vol. 70, no. 2, pp. 217–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. C. H. Chang, J. Horton, D. Schoenfeld, et al., “Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and Eastern cooperative oncology group study,” Cancer, vol. 52, no. 6, pp. 997–1007, 1983.
  59. V. R. Recinos, B. M. Tyler, K. Bekelis et al., “Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model,” Neurosurgery, vol. 66, no. 3, pp. 530–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Walbert, M. R. Gilbert, M. D. Groves et al., “Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma,” Journal of Neuro-Oncology, vol. 102, no. 2, pp. 273–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Menei and J. P. Benoit, “Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma,” Acta Neurochirurgica, supplement 88, pp. 51–55, 2003. View at Scopus
  62. A. J. Sawyer, J. M. Piepmeier, and W. M. Saltzman, “New methods for direct delivery of chemotherapy for treating brain tumors,” Yale Journal of Biology and Medicine, vol. 79, no. 3-4, pp. 141–152, 2006. View at Scopus
  63. M. Henze, W. Pietsch, V. Burwitz, et al., “Confirmation of a recent optical nova candidate in M 31 and H-alpha identification of seven M 31 novae,” The Astronomer's Telegram #1602, 2008.
  64. J. Xie, S. T. Ruo, and C. H. Wang, “Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro,” Journal of Biomedical Materials Research A, vol. 85, no. 4, pp. 897–908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Xie, J. C. M. Marijnissen, and C. H. Wang, “Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro,” Biomaterials, vol. 27, no. 17, pp. 3321–3332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. A. G. Zeimet, D. Reimer, A. C. Radl et al., “Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer,” Anticancer Research, vol. 29, no. 7, pp. 2803–2808, 2009. View at Scopus
  67. D. K. Armstrong and M. F. Brady, “Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time,” Journal of Clinical Oncology, vol. 24, no. 28, pp. 4531–4533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Lu, J. Wang, M. G. Wientjes, and J. L. S. Au, “Intraperitoneal therapy for peritoneal cancer,” Future Oncology, vol. 6, no. 10, pp. 1625–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. C. W. E. Redman, F. G. Lawton, D. M. Luesley, E. J. Buxton, and G. Blackledge, “Problems of peritoneal access in intraperitoneal treatment and monitoring of ovarian cancer,” British Journal of Obstetrics and Gynaecology, vol. 96, no. 1, pp. 97–101, 1989. View at Scopus
  70. M. Markman and J. L. Walker, “Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment,” Journal of Clinical Oncology, vol. 24, no. 6, pp. 988–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. D. S. Alberts, E. A. Surwit, Y. M. Pen et al., “Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration,” Cancer Research, vol. 48, no. 20, pp. 5874–5877, 1988. View at Scopus
  72. R. Demicheli, G. Bonciarelli, A. Jirillo, et al., “Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administration,” Tumori, vol. 71, no. 1, pp. 63–68, 1985.
  73. W. R. Robinson, N. Davis, and A. S. Rogers, “Paclitaxel maintenance chemotherapy following intraperitoneal chemotherapy for ovarian cancer,” International Journal of Gynecological Cancer, vol. 18, no. 5, pp. 891–895, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. S. B. Howell, C. E. Pfeifle, and R. A. Olshen, “Intraperitoneal chemotherapy with Melphalan,” Annals of Internal Medicine, vol. 101, no. 1, pp. 14–18, 1984. View at Scopus
  75. R. J. Morgan Jr, J. H. Doroshow, T. Synold et al., “Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics,” Clinical Cancer Research, vol. 9, no. 16, pp. 5896–5901, 2003. View at Scopus
  76. P. J. O'Dwyer, F. P. LaCreta, J. P. Daugherty et al., “Phase I pharmacokinetic study of intraperitoneal etoposide,” Cancer Research, vol. 51, no. 8, pp. 2041–2046, 1991. View at Scopus
  77. E. F. McClay, R. Goel, P. Andrews et al., “A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide,” British Journal of Cancer, vol. 68, no. 4, pp. 783–788, 1993. View at Scopus
  78. Z. Lu, M. Tsai, D. Lu, J. Wang, M. G. Wientjes, and J. L. S. Au, “Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer,” Journal of Pharmacology and Experimental Therapeutics, vol. 327, no. 3, pp. 673–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Tsai, Z. Lu, J. Wang, T. K. Yeh, M. G. Wientjes, and J. L. S. Au, “Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel,” Pharmaceutical Research, vol. 24, no. 9, pp. 1691–1701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Gaudron, C. Eilles, G. Ertl, and K. Kochsiek, “Adaptation to cardiac dysfunction after myocardial infarction,” Circulation, vol. 87, no. 5, pp. IV83–IV89, 1993. View at Scopus
  81. H. Zhang, X. Chen, E. Gao et al., “Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction,” Circulation Research, vol. 107, no. 6, pp. 800–809, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Anversa, “Myocyte death in the pathological heart,” Circulation Research, vol. 86, no. 2, pp. 121–124, 2000. View at Scopus
  83. P. Anversa, A. Leri, and J. Kajstura, “Cardiac Regeneration,” Journal of the American College of Cardiology, vol. 47, no. 9, pp. 1769–1776, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Bolli, M. O. Jeroudi, B. S. Patel et al., “Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 12, pp. 4695–4699, 1989. View at Scopus
  85. J. C. Sy, G. Seshadri, S. C. Yang et al., “Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction,” Nature Materials, vol. 7, no. 11, pp. 863–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Lamprecht, H. Rodero Torres, U. Schäfer, and C. M. Lehr, “Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease,” Journal of Controlled Release, vol. 69, no. 3, pp. 445–454, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Maulik and M. Thirunavukkarasu, “Growth factor/s and cell therapy in myocardial regeneration,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 2, pp. 219–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. R. Passier, L. W. Van Laake, and C. L. Mummery, “Stem-cell-based therapy and lessons from the heart,” Nature, vol. 453, no. 7193, pp. 322–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. V. F. M. Segers and R. T. Lee, “Stem-cell therapy for cardiac disease,” Nature, vol. 451, no. 7181, pp. 937–942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. T. T. Rissanen, J. E. Markkanen, K. Arve et al., “Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model,” The FASEB Journal, vol. 17, no. 1, pp. 100–102, 2003. View at Scopus
  91. M. Hedman, J. Hartikainen, M. Syvanne, et al., “Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT),” Circulation, vol. 107, no. 21, pp. 2677–2683, 2003.
  92. M. Simons, B. H. Annex, R. J. Laham et al., “Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial,” Circulation, vol. 105, no. 7, pp. 788–793, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. T. D. Henry, B. H. Annex, G. R. McKendall et al., “The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis,” Circulation, vol. 107, no. 10, pp. 1359–1365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. F. R. Formiga, B. Pelacho, E. Garbayo et al., “Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model,” Journal of Controlled Release, vol. 147, no. 1, pp. 30–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Wu and A. Horuzsko, “Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells,” Human Immunology, vol. 70, no. 5, pp. 353–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. G. Ano, A. Esquisabel, M. Pastor, et al., “A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae,” Vaccine, vol. 29, no. 34, pp. 5758–5764, 2011.
  97. S. Taranejoo, M. Janmaleki, M. Rafienia, M. Kamali, and M. Mansouri, “Chitosan microparticles loaded with exotoxin A subunit antigen for intranasal vaccination against Pseudomonas aeruginosa: an in vitro study,” Carbohydrate Polymers, vol. 83, no. 4, pp. 1854–1861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Garlapati, N. F. Eng, T. G. Kiros et al., “Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis,” Vaccine, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. D. T. O'Hagan, M. Singh, and J. B. Ulmer, “Microparticles for the delivery of DNA vaccines,” Immunological Reviews, vol. 199, pp. 191–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. R. K. Evans, D. M. Zhu, D. R. Casimiro et al., “Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines,” Journal of Pharmaceutical Sciences, vol. 93, no. 7, pp. 1924–1939, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Caputo, K. Sparnacci, B. Ensoli, and L. Tondelli, “Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines,” Current Drug Delivery, vol. 5, no. 4, pp. 230–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. S. P. Kasturi, K. Sachaphibulkij, and K. Roy, “Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines,” Biomaterials, vol. 26, no. 32, pp. 6375–6385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. D. N. Nguyen, J. J. Green, J. M. Chan, R. Langer, and D. G. Anderson, “Polymeric materials for gene delivery and DNA vaccination,” Advanced Materials, vol. 21, no. 8, pp. 847–867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. I. G. de Quevedo, L. Siminerio, R. L'Heveder, and K. M. Narayan, “Challenges in real-life diabetes translation research: early lessons from BRIDGES projects,” Diabetes Research and Clinical Practice, vol. 95, no. 3, pp. 317–325, 2012. View at Publisher · View at Google Scholar
  105. S. Matsumoto, H. Noguchi, Y. Yonekawa et al., “Pancreatic islet transplantation for treating diabetes,” Expert Opinion on Biological Therapy, vol. 6, no. 1, pp. 23–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Onaca, G. B. Klintmalm, and M. F. Levy, “Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus,” Nutrition in Clinical Practice, vol. 19, no. 2, pp. 154–164, 2004. View at Scopus
  107. R. P. Robertson and J. S. Harmon, “Pancreatic islet β-cell and oxidative stress: the importance of glutathione peroxidase,” FEBS Letters, vol. 581, no. 19, pp. 3743–3748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. H. Kaneto, Y. Kajimoto, Y. Fujitani et al., “Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction,” Diabetologia, vol. 42, no. 9, pp. 1093–1097, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Luca, G. Basta, R. Calafiore et al., “Multifunctional microcapsules for pancreatic islet cell entrapment: design, preparation and in vitro characterization,” Biomaterials, vol. 24, no. 18, pp. 3101–3114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Emami, H. Hamishehkar, A. R. Najafabadi et al., “A novel approach to prepare insulin-loaded poly (lactic-co-glycolic acid) microcapsules and the protein stability study,” Journal of Pharmaceutical Sciences, vol. 98, no. 5, pp. 1712–1731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. R. C. Mundargi, V. Rangaswamy, and T. M. Aminabhavi, “Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery,” Journal of Microencapsulation, vol. 28, no. 5, pp. 384–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. M. J. Cozar-Bernal, M. A. Holgado, J. L. Arias, et al., “Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation,” Journal of Microencapsulation, vol. 28, no. 5, pp. 430–441, 2011.
  113. S. S. Iyer, W. H. Barr, and H. T. Karnes, “A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant,” International Journal of Pharmaceutics, vol. 340, no. 1-2, pp. 119–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. J. M. Chan, P. M. Valencia, L. Zhang, R. Langer, and O. C. Farokhzad, “Polymeric nanoparticles for drug delivery,” Methods in Molecular Biology, vol. 624, pp. 163–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation,” Accounts of Chemical Research, vol. 44, no. 10, pp. 1123–1134, 2011. View at Publisher · View at Google Scholar
  116. J. Shi, Z. Xiao, A. R. Votruba, C. Vilos, and O. C. Farokhzad, “Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering rna delivery,” Angewandte Chemie, vol. 50, no. 31, pp. 7027–7031, 2011. View at Publisher · View at Google Scholar · View at Scopus